These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 11675828)
81. GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries. Askari AT; Lincoff AM Cleve Clin J Med; 2002 Jul; 69(7):554-60. PubMed ID: 12109639 [TBL] [Abstract][Full Text] [Related]
82. Thrombolysis in the management of acute myocardial infarction. Current status and future perspectives. Verheugt F Rev Port Cardiol; 1998 Dec; 17(12):959-65. PubMed ID: 9973856 [TBL] [Abstract][Full Text] [Related]
83. Too much, too little, or none at all: dealing with substandard and fake drugs. Wan Po AL Lancet; 2001 Jun; 357(9272):1904. PubMed ID: 11425409 [No Abstract] [Full Text] [Related]
84. Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial. Savonitto S; Armstrong PW; Lincoff AM; Jia G; Sila CA; Booth J; Terrosu P; Cavallini C; White HD; Ardissino D; Califf RM; Topol EJ Eur Heart J; 2003 Oct; 24(20):1807-14. PubMed ID: 14563339 [TBL] [Abstract][Full Text] [Related]
85. The ideal fibrinolytic: can drug design improve clinical results? Van de Werf FJ Eur Heart J; 1999 Oct; 20(20):1452-8. PubMed ID: 10493843 [No Abstract] [Full Text] [Related]
86. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction. Johnson TJ S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948 [No Abstract] [Full Text] [Related]
87. What do new lytics add to t-PA? Van de Werf F Am Heart J; 1999 Aug; 138(2 Pt 2):S115-20. PubMed ID: 10426869 [TBL] [Abstract][Full Text] [Related]
88. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy]. Chernetsov VA Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019 [No Abstract] [Full Text] [Related]
89. Glycoprotein IIb/IIIa receptor antagonists in the treatment of acute ST elevation MI: from hypotheses to unexpected recent observations. Ross AM J Thromb Thrombolysis; 2003 Apr; 15(2):85-9. PubMed ID: 14618074 [TBL] [Abstract][Full Text] [Related]
93. GPIIbIIIa inhibitors as adjunctive therapy in acute myocardial infarction. Salame M; Verheye S; More R; King SB; Chronos N Int J Cardiol; 1999 Jun; 69(3):231-6. PubMed ID: 10402105 [TBL] [Abstract][Full Text] [Related]
95. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. Topol EJ Circulation; 1998 Jan; 97(2):211-8. PubMed ID: 9445175 [No Abstract] [Full Text] [Related]
96. Logic and logistics: conundrum in reperfusion treatment for acute myocardial infarction. Brener S; Topol EJ Heart; 1999 Oct; 82(4):402-3. PubMed ID: 10490544 [No Abstract] [Full Text] [Related]
97. [The optimization of the results with the use of thrombolytic therapy in acute myocardial infarct (I)]. Cerveró Martí A Med Clin (Barc); 1993 May; 100(17):668-74. PubMed ID: 8497174 [No Abstract] [Full Text] [Related]
98. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct]. Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820 [No Abstract] [Full Text] [Related]
99. Fibrinolytic treatment for elderly patients with acute myocardial infarction. Estess JM; Topol EJ Heart; 2002 Apr; 87(4):308-11. PubMed ID: 11906993 [No Abstract] [Full Text] [Related]
100. Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Nordt TK; Bode C Heart; 2003 Nov; 89(11):1358-62. PubMed ID: 14594904 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]